Author:
Ahn Myung-Ju,Bondarenko Igor,Kalinka Ewa,Cho Byoung Chul,Sugawara Shunichi,Gálffy Gabriella,Shim Byoung Yong,Kislov Nikolay,Nagarkar Rajnish,Demedts Ingel,Gans Steven J.M.,Mendoza Oliva Dolores,Stewart Ross,Lai Zhongwu,Mann Helen,Shi Xiaojin,Hussein Maen
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference36 articles.
1. Immunotherapy for advanced non-small cell lung cancer: a decade of progress;Shields;Am Soc Clin Oncol Educ Book,2021
2. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018
3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019
4. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC;Socinski;N Engl J Med,2018
5. Update 2020: Management of non-small cell lung cancer;Alexander;Lung,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献